Moderna Pfizer Joe Biden Covid-19 American pharmaceutical and biotechnology business Moderna (MRNA) deteriorated following last week’s stock rise. The healthcare tycoon lost 7.14% on Monday.
Author: D.I.P Chronicles
https://www.linkedin.com/in/david-owusu-akyeaw-04a71923/
Digital Information Publishing 